945925-78-0

Basic information

• Product Name: 4,5,6,7-tetrahydro-3-iodo-1H-Indazole
• Synonyms: 4,5,6,7-tetrahydro-3-iodo-1H-Indazole;3-Iodo-4,5,6,7-tetrahydro-1H-indazole
• CAS NO: 945925-78-0
• Molecular Formula: C₇H₉IN₂
• Molecular Weight: 248.06423
• Mol File: 945925-78-0.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 373.4±42.0 °C(Predicted)
• Appearance: /
• Density: 1.909±0.06 g/cm3(Predicted)
• PKA: 12.52±0.20(Predicted)
• CAS DataBase Reference: 4,5,6,7-tetrahydro-3-iodo-1H-Indazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5,6,7-tetrahydro-3-iodo-1H-Indazole(945925-78-0)
• EPA Substance Registry System: 4,5,6,7-tetrahydro-3-iodo-1H-Indazole(945925-78-0)

Safety Data

• Hazardous Substances Data: 945925-78-0(Hazardous Substances Data)

Upstream product

• 2305-79-5 4,5,6,7-tetrahydro-1H-indazole 

Relevant articles and documents

PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, and Formula IV or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula I: and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

SUBSTITUTED INDAZOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula (I) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.